Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory M2 monocytes

METHODS OF VACCINATION IN PREMALIGNANT SETTINGS

Compositions for cancer therapy and methods

CATIONIC LIQUID CRYSTALLINE NANOPARTICLES

Peptide, complex of peptide and siRNA, and methods of use thereof

Organic compositions to treat EPAS1-related diseases

MICRO-RNA FAMILY THAT MODULATES FIBROSIS AND USES THEREOF

Methods and compositions to prevent and treat inflammation and allergic reactions

Edible plant-derived microvesicle compositions for diagnosis and treatment of disease

MICRO-RNAS THAT MODULATE LYMPHANGIOGENESIS AND INFLAMMATORY PATHWAYS IN LYMPHATIC VESSEL CELLS

INHIBITORS OF DEK PROTEIN AND RELATED METHODS

Anti-inflammatory treatment via inhibition of endothelial cell kinesin light chain 1, variant 1 (KLC1C)

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

EPIGENETIC INHIBITORS FOR SENSITIZING HEMATOLOGIC OR OTHER MALIGNANCIES TO GLUCOCORTICOID THERAPY

Thymidine kinase gene

Nucleotide, polypeptide and applications thereof

Double-stranded oligo RNA structure comprising miRNA

Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer

Ketohexokinase (KHK) iRNA compositions and methods of use thereof

Use of a combination of Dbait molecule and PARP inhibitors to treat cancer

SELECTIVE DESTRUCTION OF CELLS

Methods for treating hepatitis B infection

COMPOSITIONS COMPRISING APTAMERS AND NUCLEIC ACID PAYLOADS AND METHODS OF USING THE SAME

Cancer Treatment Based on Delivery of Oligoes via Gap Junctions from Human Mesenchymal Stem Cells (hMSC)

Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

Methods for cancer treatment

Pharmaceutical composition comprising particles comprising a complex of a double-stranded polyribonucleotide and a polyalkyleneimine

NANOCOMPLEXES FOR REMOTELY-TRIGGERED GUEST MOLECULE RELEASE AND METHODS FOR FABRICATING THE SAME

RNAi inhibition of alpha-ENaC expression

COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS

SBE aptamers for treating IL-17a related diseases and conditions

Use of therapeutic agents

COMPOSITIONS AND METHODS FOR MODIFIED DENDRIMER NANOPARTICLE DELIVERY

HUMAN ORAL MUCOSA STEM CELL SECRETOME

POLYMALIC ACID-BASED NANOBIOPOLYMER COMPOSITIONS

Use of oligonucleotides for the treatment and prevention of pain

Pharmaceutical composition comprising particles comprising a complex of a double-stranded polyribonucleotide and a polyalkyleneimine

TRPC3 as a therapeutic target for alzheimer's disease

Antisense nucleic acids

Cellular delivery of DNA intercalating agents

Combination Therapy of Acellular Pro-Tolerogenic and Pro-Inflammatory Preparations for Modulating the Immune System

Micellic assemblies

FUNCTION INHIBITOR OF SWI/SNF COMPLEXES

Oligonucleotide analogues targeting human LMNA

Methods and compositions for the treatment of retinopathy and other ocular diseases

Methods and compositions for the treatment of retinopathy and other ocular diseases

Methods and compositions for treating a proprotein convertase subtilisin kexin (PCSK9) gene-associated disorder

Fidgetin-like 2 as a target to enhance wound healing

COMPOSITIONS AND METHODS FOR TREATING CANCER

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

Hepatitis B virus (HBV) iRNA compositions and methods of use thereof

Therapeutic agent for a lung disease and/or method for screening for the same

Regulation of RAN translation by PKR and eIF2A-P pathways

ANTI-IL-6 ANTIBODIES FOR THE TREATMENT OF ANEMIA

Use of upstream open reading frame 45aa-uORF nucleotide sequence of PTEN gene and polypeptide coded by 45aa-uORF

Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof

Immune modulation with TLR9 agonists for cancer treatment

Myostatin iRNA compositions and methods of use thereof

FABP4 as a therapeutic target in skin diseases

ENHANCED THERAPEUTIC AGENT AND NUCLEIC ACID DELIVERY VIA HDL OR RECONSTITUTED HDL NANOPARTICLES

Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLKB1), and kininogen 1 (KNG1) iRNA compositions and methods of use thereof

m6A mRNA MODIFICATION IN CANCER TREATMENT

Lipid membrane structure for delivery into siRNA cell

TREATMENT OF ANGIOGENESIS-ASSOCIATED DISEASES USING RNA COMPLEXES THAT TARGET ANGPT2 AND PDGFB

NUCLEIC ACID-BASED ASSEMBLY AND USES THEREOF

RNA COMPOSITIONS FOR GENOME EDITING

NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF

Methods for reducing post-operative cognitive dysfunction (POCD)

Double-stranded nucleic acid molecule, DNA, vector, cancer cell growth inhibitor, cancer cell migration inhibitor, and drug

NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

Methods of reducing expression of x-inactivation escapee genes and autosomal genes

Gemcitabine Derivatives for Cancer Therapy

Methods for overcoming glucocorticoid resistance and for determining glucocorticoid resistance potential in cancer

Compositions and methods for the treatment of hemoglobinopathies

Method for inhibiting calcification of a smooth muscle cell (SMC)

Methods and compositions for managing vascular conditions

FORMULATION COMPRISING EXTRACELLULAR VESICLES, METHOD FOR PRODUCING THE SAME, AND USES THEREOF

Compositions and methods for prevention and treatment of hearing loss

PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF CHRONIC DISEASE

METHODS FOR TREATING AND PREVENTING ALLERGIES AND ACUTE ALLERGIC RESPONSES

ERBB3 Activators in Hearing Restoration

Methods and compositions for the treatment of retinopathy and other ocular diseases

LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY

Antibody-drug conjugates and uses thereof

NANOSCALE CARRIERS FOR THE DELIVERY OR CO-DELIVERY OF CHEMOTHERAPEUTICS, NUCLEIC ACIDS AND PHOTOSENSITIZERS

Inhibition of Chemokine CCL7 or Receptor CCR3 of Same for the Treatment and Diagnosis of Prostate Cancer

Compositions and methods for loading extracellular vesicles with chemical and biological agents/molecules

Methods for Treating Obesity of a Subject Suffering from Obesity

Cationic lipid

Serpina1 iRNA compositions and methods of use thereof

Therapeutic drug for Alport's syndrome

Combination therapies for the treatment of alzheimer's disease and related disorders

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Allele specific modulators of P23H rhodopsin

Staufen1 agents and associated methods

MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes

Cholestosome vesicles for incorporation of molecules into chylomicrons

Compositions and Methods for Dengue Virus Chimeric Constructs in Vaccines

FORMULATIONS OF POLYINOSINIC ACID AND POLYCYTIDYLIC ACID FOR THE PREVENTION OF UPPER RESPIRATORY TRACT INFECTIONS

Targeted nanocarriers for the administration of immunosuppressive agents

MODULATION OF APOLIPOPROTEIN CIII (APOCIII) EXPRESSION

Agents and methods for treating and preventing seborrheic keratosis

MRNA combination therapy for the treatment of cancer

METHODS FOR INCREASING NEURONAL SURVIVAL

Immune modulation with TLR9 agonists for cancer treatment

COMPOSITIONS AND METHODS FOR ANALYZING HETEROGENEOUS SAMPLES

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

SHP INHIBITOR COMPOSITIONS AND USES FOR CHIMERIC ANTIGEN RECEPTOR THERAPY

Peptide-polynucleotide complex for polynucleotide transfection

Methods and products for nucleic acid production and delivery

CFTR MRNA compositions and related methods and uses

Compositions and methods for the treatment of hypercholesterolemia

Methods for the treatment of subjects having a hepatitis b virus (HBV) infection

COMPOSITIONS, METHODS AND KITS FOR CHARACTERIZING AND SCREENING FOR SMALL CELL OVARIAN CARCINOMA

Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene

Technique for treating cancer using structurally-reinforced S-TuD

Complement component C5 iRNA compositions and methods of use thereof

COMPLEMENT COMPONENT C5 IRNA COMPOSITIONS AND METHODS OF USE THEREOF

Methods and compositions for the treatment of cancer or other diseases

Lin28-mediated control of let-7 biogenesis

LYPD1 INHIBITOR AND METHOD FOR PRODUCING BIOLOGICAL TISSUE USING SAME

Oligomers and oligomer conjugates

PLASMA CELL CYTOKINE VEHICLE CONTAINING FUSION PROTEINS FOR TARGETED INTRODUCTION OF SIRNA INTO CELLS AND TISSUES

MEDICAL USE OF NOTCH4 OR INHIBITORS THEREOF

Method for designing RIG-I ligands

METHOD FOR TREATING SCHIZOPHRENIA

Method for assessing the efficacy of IMiDs and composition or combination for use in treating IMiD sensitive diseases

Modified L-Nucleic Acid

THERAPIES BASED ON CONTROL OF REGULATORY T CELL STABILITY AND FUNCTION VIA A NEUROPILIN-1:SEMAPHORIN AXIS

Methods of treating diabetic nephropathy by administering an anti-vegf-b (vascular endothelial growth factor-b) antibody

METHODS OF INHIBITING CANCER STEM CELLS WITH HMGA1 INHIBITORS

Physiologically active substance carrier

HIPPO AND DYSTROPHIN COMPLEX SIGNALING IN CARDIOMYOCYTE RENEWAL

BLOCK COPOLYMERS AND USES THEREOF

Modulation of Factor 11 expression

MEDICAMENT FOR TREATMENT OF LIVER CANCER

Methods and compositions of short small hairpin RNAs and microRNAs for wound healing

Interfering RNA molecules

Aptamers for use in inhibition and/or suppression of TLR9 activation

Dosage form for treating severe asthma

Methods for treating NLRP3 inflammasome-associated diseases, and methods of identifying agents useful therefor

RNAi FOR THE CONTROL OF FUNGI AND OOMYCETES BY INHIBITING SACCHAROPINE DEHYDROGENASE GENE

Compositions and Methods for Inhibition of Factor XII Gene Expression

CATIONIC POLYMER COATED MESOPOROUS SILICA NANOPARTICLES AND USES THEREOF

BOLAAMPHIPHILIC COMPOUNDS, COMPOSITIONS AND USES THEREOF

METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL CONDITIONS

INHIBITION OF NEDDYLATION USING GLYCYL-tRNA SYNTHETASE INHIBITORS

Therapy for metastatic urothelial cancer with the antibody-drug conjugate, sacituzumab govitecan (IMMU-132)

LIPOSOME PREPARATION HAVING HIGH-CONTENT CATIONIC LIPID COMPOUND AND USE THEREOF

Methods and compositions for inhibiting or reducing hair loss, acne, rosacea, prostate cancer, and BPH

Biomarkers for premature birth

DIAGNOSTIC AND SCREENING METHODS FOR ATOPIC DERMATITIS

MUCOSAL HEALING PROMOTER

Biodegradable lipids for the delivery of active agents

FORMULATIONS FOR THE DELIVERY OF ACTIVE INGREDIENTS

Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptides

COMPOSITION FOR PREVENTING AND TREATING ARTHRITIS, INCLUDING DNA FRAGMENT MIXTURE AND MATRIX METALLOPROTEINASE PRODUCTION INHIBITOR

Methods and compositions for treating malignant tumors associated with KRAS mutation

COMPOSITIONS AND METHODS FOR DELIVERING MICRORNA

Method for assaying MicroRNA, cancer therapeutic agent, and medical composition containing same for cancer therapy

Conjugated antisense compounds and their use

Methods and compositions for treating cancers using antisense

Drug carrier having self-assembled 3-D nucleic acid nanostructure

Targeted polymerized nanoparticles for cancer treatment

Compositions and methods for inhibiting gene expression of factor XII

Compositions and methods for treating and preventing inflammation

ANTI-INFLAMMATORY DRUG AND USES THEREOF

Lipids and lipid nanoparticle formulations for delivery of nucleic acids

Lipids and lipid compositions for the delivery of active agents

STEAP2 inhibitors for the treatment of liver cancers

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

Sterile formulation comprising a stable phosphorothioate oligonucleotide

METHODS FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES USING TRANSTHYRETIN (TTR) iRNA COMPOSITIONS

Methods and Compositions for Selecting siRNA of Improved Functionality

Nucleic acid simultaneously inhibiting expression of mTOR gene and STAT3 gene

Therapeutic targets for facioscapulohumeral muscular dystrophy

Pharmaceutical composition for preventing or treating hepatitis B

Modulation of Lnc05 expression

Application of ERH Gene in the Preparation of Bladder Cancer Diagnosis and Treatment Products

Compositions and methods for reactivating latent immunodeficiency virus

MODULATION OF TMPRSS6 EXPRESSION

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

SYSTEMS, METHODS AND COMPOSITIONS FOR OPTICAL STIMULATION OF TARGET CELLS

COMPOSITIONS AND METHODS TO INDUCE TARGETED APOPTOSIS BY MODULATING PROTEIN TYROSINE PHOSPHATASE 13 (PTPN13)

USE OF A SIRNA FOR TREATING CANCER

MODULATION OF TUMOR CELL SUSCEPTIBILITY

Compositions and methods used in diagnosing and treating colorectal cancer

Methods for intracellular delivery and enhanced gene targeting

Consequences of a defective switch in cutaneous squamous cell carcinoma

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

RNA COMPOSITIONS FOR GENOME EDITING

Engineered antibodies and uses thereof

Reducing damage from radiation therapy and increasing cancer kill rates by interweaving of low and high dose sessions

Thymidine kinase diagnostic assay for gene therapy applications

Molecular adjuvants for enhanced cytosolic delivery of active agents

Use of polyinosinic-polycytidylic acid compositions in treatment of malignant effusion

Compositions and methods for suppressing MSUT2

ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES

TUMOR ANTIGEN SPECIFIC ANTIBODIES AND TLR3 STIMULATION TO ENHANCE THE PERFORMANCE OF CHECKPOINT INTERFERENCE THERAPY OF CANCER

Methods for promoting reinnervation of auditory hair cells

Lipid nanoparticle compositions and methods for mRNA delivery

Compositions and methods for transport across the blood brain barrier

Pharmaceutical compositions and methods for potentiating gene silencing

COMPOUNDS AND METHODS FOR MODULATION OF TRANSCRIPT PROCESSING

Method of Encapsulating a Nucleic Acid in a Lipid Nanoparticle Host

Methods and Compositions for Selecting siRNA of Improved Functionality

Oligonucleotide compositions with enhanced efficiency

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

DELIVERY OF dsRNA TO ARTHROPODS

Carrier Nanoparticles And Related Compositions, Methods And Systems

Optimized in vivo delivery system with endosomolytic agents for nucleic acid conjugates

TREATMENT OF HORMONAL DISORDERS OF GROWTH

Estrogen sensing through GPER1 regulates normal and malignant liver growth

Methods for directed folding assembly or dimerization of proteins by templated assembly reactions

Method of treating cancer and method of sensitizing cancer cells to the action of chemotherapeutic agents via growth hormone receptor antagonists or knock down

Compositions and methods for improving immune system function

Inhibitors of cytoplasmic histone deacetylase 4 complex for treating or preventing vascular or valve calcification

Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene

Compositions and Methods for Inhibiting Expression of Transthyretin

Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway

Recombinant protein-based method for the delivery of silencer RNA to target the brain

Heterocyclic compounds for the treatment of arenavirus

Non-alcoholic fatty liver regulator 14-3-3 protein

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER AND METABOLIC DISEASES

LIPID NANOPARTICLES FOR TRANSFECTION AND RELATED METHODS

Compositions and methods of treating muscle atrophy and myotonic dystrophy

Nucleic Acid Complexes

Combination immunotherapies for treatment of cancer

Use of microRNA-188-5p for treating Alzheimer's disease

Methods for treatment of cancer by targeting SIRT5

Methods for treating PTEN deficient epithelial cancers using a combination of anti-PI3KBETA and anti-immune checkpoint agents

Methods of identifying and treating poor-prognosis cancers

Composition for promoting production of immunostimulatory factor

Fidgetin-like 2 as a target to enhance wound healing

TMPRSS6 iRNA compositions and methods of use thereof

SELECTIVE LOCAL INHIBITION OF TNFR1-MEDIATED FUNCTIONS AT THE SITE OF ANTIGEN/ALLERGEN PRESENTATION

Compositions and methods for promoting the mineralization of biological tissue

METHOD FOR INCREASING NEPRILYSIN EXPRESSION AND ACTIVITY

THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B

Treatment of synucleinopathies

Disruption of EGFR-SAR1 interaction for cancer treatment

Methods for diagnosing IDH-mutant cell proliferation disorders

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

CNS TARGETING AAV VECTORS AND METHODS OF USE THEREOF

Organic compositions to treat HSF1-related diseases

Cancer Treatment and Immune System Regulation Through FAT10 Pathway Inhibition

CAMK2D antisense oligonucleotides and uses thereof

Inhibition of KMT2D for the treatment of cancer

THERAPEUTIC AGENT FOR PERIODONTITIS AND COMPOSTION FOR TREATING PERIODONTITIS

COMPOSITIONS AND METHODS FOR THE MANUFACTURE OF LIPID NANOPARTICLES

Methods of treating cancer

Methods and compositions for treating disorders associated with cortico-hippocampal hyperactivity

Agents for improved delivery of nucleic acids to eukaryotic cells

Therapeutic compositions

MicroRNA-200 based approaches for modulating bone formation inhibition and bone regeneration

GLYCOCONJUGATES OF RNA INTERFERENCE AGENTS

Treatments of non-alcoholic steatohepatitis (NASH)

Double-stranded nucleic acid molecule and use thereof

METHODS AND COMPOSITIONS FOR MODULATING CANCER STEM CELLS

ANTAGONIST OF MINERALOCORTICOID RECEPTOR FOR THE TREATMENT OF OSTEOARTHRITIS

Wound healing composition

Methods for treating hair loss disorders

Methods of modulating melanosome pH and melanin level in cells

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

Targeting ligands

Modulation of TJP1 expression to regulate regeneration of heart cells

Therapeutic targets involved in the progression of nonalcoholic steatohepatitis (NASH)

EGFR gene expression-suppressing siRNA, precursor of same, and applications thereof

Use of CDK9 inhibitors to reduce cartilage degradation

Oil-in-water emulsions that contain nucleic acids

Alpha-v beta-6 integrin ligands and uses thereof

IDENTIFICATION AND USE OF TARGET GENES FOR CONTROL OF PLANT PARASITIC NEMATODES

Anti-CTLA4 antibodies and methods of making and using the same

Compositions and methods for delivering messenger RNA

FUNCTIONAL RNA AND SMALL-MOLECULE DRUG THERAPEUTIC COMPLEXES AND NANOPARTICLE DELIVERY VEHICLES

Functionalized nucleic acid nanostructures for RNA delivery

Lipid formulations for delivery of therapeutic agents

MANIPULATION OF REGULATORY T CELL AND DC FUNCTION BY TARGETING NEURITIN GENE USING ANTIBODIES, AGONISTS AND ANTAGONISTS

Gold nanoparticle based formulation for use in cancer therapy

Delivery compositions, and methods of making and using same

RNA interference in ocular indications

Compounds for detecting and treating

Method of releasing the suppression of egg maturation in economically-important prawn/shrimp species

Organic compositions to treat APOC3-related diseases

Methods and compositions for treating cancer

Surfactant peptide nanostructures and uses thereof in drug delivery

Compositions and methods for nanoparticle lyophile forms

Oligonucleotide compounds for targeting huntingtin mRNA

Use of immobilization particles for removal of microorganisms and/or chemicals

Therapeutic compositions and methods of making and using the same

COMPOSITIONS AND METHODS OF INHIBITING GENE EXPRESSION IN A LUNG

Pharmaceutical composition for treating cancer comprising microrna as active ingredient

COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE

TRPM4 CHANNEL INHIBITORS FOR STROKE TREATMENT

Regimens and Compositions for AAV-Mediated Passive Immunization of Airborne Pathogens

Pharmaceutical composition for treating and/or preventing cancer

EXTENDED-RELEASE DRUG DELIVERY COMPOSITIONS

Modulators of telomere disease